What does it mean?
The ABOGRAFT study is a multi-centre international study to explore the effects of local antibiotics to prevent joint infection in patients undergoing total joint replacement of the hip.
To reduce the number of patients suffering from prosthetic joint infection after hip replacement.
This is a pragmatic multi-centre international randomized and double-blinded study. Patients are allocated into two groups: the treatment group will receive antibiotic impregnated bone graft while the non-treatment group will receive a placebo. The study protocol will be submitted to BMJ Open. If, in the meantime you would like to have access to the full protocol, send us an email.
Contact us: firstname.lastname@example.org
Get involved: Does your centre want to join the ABOGRAFT consortium? Contact us!